Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen L Hauser

Showing results (181-190 of 322) with videos related to

Pageof 33
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 4, 2020
Ataxin-1 regulates B cell function and the severity of autoimmune experimental encephalomyelitisAlessandro Didonna, Ester Canto Puig, Qin Ma, et al.
The New England Journal of Medicine|February 15, 2008
B-cell depletion with rituximab in relapsing-remitting multiple sclerosisStephen L Hauser, Emmanuelle Waubant, Douglas L Arnold, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2008
Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosisStacy J Caillier, Farren Briggs, Bruce A C Cree, et al.
American Journal of Human Genetics|April 17, 2004
Methods for high-density admixture mapping of disease genesNick Patterson, Neil Hattangadi, Barton Lane, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 19, 2011
Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disabilityStefan D Roosendaal, Kerstin Bendfeldt, Hugo Vrenken, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 25, 2018
Toward a low-cost, in-home, telemedicine-enabled assessment of disability in multiple sclerosisRiley Bove, Carolyn Bevan, Elizabeth Crabtree, et al.
Journal of Neurology|October 31, 2023
Ocrelizumab exposure in relapsing-remitting multiple sclerosis: 10-year analysis of the phase 2 randomized clinical trial and its extensionLudwig Kappos, Anthony Traboulsee, David K B Li, et al.
Neurology|December 24, 2017
Ovarian aging is associated with gray matter volume and disability in women with MSJennifer S Graves, Roland G Henry, Bruce A C Cree, et al.
The Lancet. Neurology|October 21, 2006
Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive studyLisa F Barcellos, Brinda B Kamdar, Patricia P Ramsay, et al.
BMC Genomics|August 9, 2007
SNPs in Multi-species Conserved Sequences (MCS) as useful markers in association studies: a practical approachJacob L McCauley, Shannon J Kenealy, Elliott H Margulies, et al.
Pageof 33

Showing results (181-190 of 322) with videos related to

Sort By:
Pageof 33
Proceedings of the National Academy of Sciences of the United States of America|September 4, 2020
Ataxin-1 regulates B cell function and the severity of autoimmune experimental encephalomyelitisAlessandro Didonna, Ester Canto Puig, Qin Ma, et al.
The New England Journal of Medicine|February 15, 2008
B-cell depletion with rituximab in relapsing-remitting multiple sclerosisStephen L Hauser, Emmanuelle Waubant, Douglas L Arnold, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2008
Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosisStacy J Caillier, Farren Briggs, Bruce A C Cree, et al.
American Journal of Human Genetics|April 17, 2004
Methods for high-density admixture mapping of disease genesNick Patterson, Neil Hattangadi, Barton Lane, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 19, 2011
Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disabilityStefan D Roosendaal, Kerstin Bendfeldt, Hugo Vrenken, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 25, 2018
Toward a low-cost, in-home, telemedicine-enabled assessment of disability in multiple sclerosisRiley Bove, Carolyn Bevan, Elizabeth Crabtree, et al.
Journal of Neurology|October 31, 2023
Ocrelizumab exposure in relapsing-remitting multiple sclerosis: 10-year analysis of the phase 2 randomized clinical trial and its extensionLudwig Kappos, Anthony Traboulsee, David K B Li, et al.
Neurology|December 24, 2017
Ovarian aging is associated with gray matter volume and disability in women with MSJennifer S Graves, Roland G Henry, Bruce A C Cree, et al.
The Lancet. Neurology|October 21, 2006
Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive studyLisa F Barcellos, Brinda B Kamdar, Patricia P Ramsay, et al.
BMC Genomics|August 9, 2007
SNPs in Multi-species Conserved Sequences (MCS) as useful markers in association studies: a practical approachJacob L McCauley, Shannon J Kenealy, Elliott H Margulies, et al.
Pageof 33